Clinical trials, ototoxicity grading scales and the audiologist’s role in therapeutic decision making

References

• American Speech-Language-Hearing Association (ASHA). 1994. “Guidelines for the Audiologic Management of Individuals Receiving Cochleotoxic Drug Therapy.” American Speech-Language-Hearing Association 36: 1–19. doi:10.1044/policy.gl1994-00003.
   Google Scholar
• Bass, J. K., J. Huang, A. Onar-Thomas, K. W. Chang, S. P. Bhaga, M. Chintagumpala, U. Bartels, et al. 2014. “Concordance between the Chang and the International Society of Pediatric Oncology (SIOP) Ototoxicity Grading Scales in Patients Treated with Cisplatin for Medulloblastoma.” Pediatric Blood & Cancer 61: 601–605. doi:10.1002/pbc.24830.
   PubMed Web of Science ®Google Scholar
• Brock, P. R., S. C. Bellman, E. C. Yeomans, C. R. Pinkerton, and J. Pritchard. 1991. “Cisplatin Ototoxicity in Children: A Practical Grading System.” Medical and Pediatric Oncology 19 (4): 295–300. doi:10.1002/mpo.2950190415.
   PubMedGoogle Scholar
• Brock, P. R., K. R. Knight, D. R. Freyer, K. C. Campbell, P. S. Steyger, B. W. Blakley, S. R. Rassekh, et al. 2012. “Platinum-induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale.” Journal of Clinical Oncology 30 (19): 2408–2417. doi:10.1200/JCO.2011.39.1110.
   PubMed Web of Science ®Google Scholar
• Brooks, B., and K. Knight. 2017. “Ototoxicity Monitoring in Children Treated with Platinum Chemotherapy.” International Journal of Audiology 24: 1–7. doi:10.1080/14992027.2017.1355570.
   Google Scholar
• Chang, K. W. 2011. “Clinically Accurate Assessment and Grading of Ototoxicity.” The Laryngoscope 121 (12): 2649–2657. doi:https://doi.org/10.1002/lary.22376.
   PubMed Web of Science ®Google Scholar
• Chang, K. W., and N. Chinosornvatana. 2010. “Practical Grading System for Evaluating Cisplatin Ototoxicity in Children.” Journal of Clinical Oncology 28 (10): 1788–1795. doi:10.1200/JCO.2009.24.4228.
   PubMed Web of Science ®Google Scholar
• Crundwell, G., P. Gomersal, and D. M. Baguley. 2016. “Ototoxicity (Cochleotoxicity) Classifications: A Review.” International Journal of Audiology 55 (2): 65–74. doi:10.3109/14992027.2015.1094188.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). 2017. “The Drug Development Process: Clinical Research.” Accessed 1 July 2017. https://www.fda.gov/ForPatients/Approvals/Drugs/ucm405622.htm
   Google Scholar
• Garinis, A., A. Kemph, A. M. Tharpe, J. H. Weitkamp, C. McEvoy, and P. Steyger. 2017. “Monitoring Neonates for Ototoxicity.” International Journal of Audiology 22: 1–8. doi:10.1080/14992027.2017.1339130.
   Google Scholar
• Gurney, J. G., and J. K. Bass. 2012. “New International Society of Pediatric Oncology Boston Ototoxicity Grading Scale for Pediatric Oncology: Still Room for Improvement.” Journal of Clinical Oncology 30 (19): 2303–2306. doi:10.1200/JCO.2011.41.3187.
   PubMed Web of Science ®Google Scholar
• ISO. 2000. ISO 7029-1, Acoustics–Statistical Distribution of Hearing Thresholds as a Function of Age. Geneva: International Organization of Standardization.
   Google Scholar
• Knight, K. R., L. Chen, D. Freyer, R. Aplenc, M. Bancroft, B. Bliss, H. Dang, et al. 2017. “Group-wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report from the Children’s Oncology Group.” Journal of Clinical Oncology 35 (4): 440–445. doi:10.1200/JCO.2016.69.2319.
   PubMed Web of Science ®Google Scholar
• Knight, K. R., D. F. Kraemer, and E. A. Neuwelt. 2005. “Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social Development.” Journal of Clinical Oncology 23 (34): 8588–8596. doi:10.1200/JCO.2004.00.5355.
   PubMed Web of Science ®Google Scholar
• Konrad-Martin, D., G. Poling, A. Garinis, C. Ortiz, J. Hopper, K. O'Connell-Bennett, and M. Dille. 2017. “Applying U.S. national Guidelines for Ototoxicity Monitoring in Adult Patients: Perspectives on Patient Populations, Service Gaps, Barriers and Solutions.” International Journal of Audiology 20: 1–16. doi:10.1080/14992027.2017.1398421.
   Google Scholar
• Konrad-Martin, D., K. M. Reavis, G. McMillan, W. J. Helt, and M. Dille. 2014. “Proposed Comprehensive Ototoxicity Monitoring Program for VA Healthcare (COMP-VA).” Journal of Rehabilitation Research and Development 51 (1): 81–100. doi:10.1682/JRRD.2013.04.0092.
   PubMed Web of Science ®Google Scholar
• Landier, W., K. Knight, F. L. Wong, J. Lee, O. Thomas, H. Kim, S. G. Kreissman, et al. 2014. “Ototoxicity in Children with High-risk Neuroblastoma: Prevalence, Risk Factors, and Concordance of Grading Scales–A Report from the Children’s Oncology Group.” Journal of Clinical Oncology 32 (6): 527–534. doi:10.1200/JCO.2013.51.2038.
   PubMed Web of Science ®Google Scholar
• Littman, T. A., A. Magruder, and D. R. Strother. 1998. “Monitoring and Predicting Ototoxic Damage Using Distortion-product Otoacoustic Emissions: Pediatric Case Study.” Journal of the American Academy of Audiology 9: 257–262.
   PubMedGoogle Scholar
• Mueller, H., and M. C. Killion. 1990. “An Easy Method for Calculating the Articulation Index.” Hearing Journal 43: 1–4.
   Google Scholar
• National Cancer Institute (NCI). 1982. “Common Toxicity Criteria.” Accessed 21 August 2017. https://www.ucdmc.ucdavis.edu/clinicaltrials/StudyTools/Documents/NCI_Toxicity_Table.pdf
   Google Scholar
• National Cancer Institute (NCI). 2010. “Common Terminology Criteria for Adverse Events (CTCAE, v 4.03.)” NCI, National Institutes of Health, Department of Health and Human Services. Accessed 21 August 2017. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-4_QuickReference_8.5x11.pdf
   Google Scholar
• Neuwelt, E., and P. Brock. 2010. “Critical Need for International Consensus on Ototoxicity Assessment Criteria.” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28 (10): 1630–1632. doi:10.1200/JCO.2009.26.7872.
   Google Scholar
• Schmitt, N. C., and B. R. Page. 2017. “Chemoradiation-induced Hearing Loss Remains a Major Concern for Head and Neck Cancer Patients.” International Journal of Audiology 20: 1–6. doi:10.1080/14992027.2017.1353710.
   Google Scholar
• Theunissen, E. A., W. A. Dreschler, M. N. Latenstein, C. R. Rasch, S. van der Baan, J. P. de Boer, A. J. Balm, et al. 2014. “A New Grading System for Ototoxicity in Adults.” Annals of Otology, Rhinology & Laryngology 123 (10): 711–718. doi:10.1177/0003489414534010.
   PubMed Web of Science ®Google Scholar